Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Tranexamic Acid in Upper Gastrointestinal Hemorrhage
NCT02903017Phase 4Completed
- Sponsor
- Kocaeli University
- Start
- Sep 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in upper gastrointestinal hemorrhage (UGIB) comparing Tranexamic acid 5% with Placebo (2 arms). Primary endpoints: Mortality at 1 month, Re-bleeding at 1 month and 3 more. Started Sep 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
upper gastrointestinal hemorrhage (UGIB)
Beyond the preview
Go deeper on NCT02903017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02903017.